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Serum Hepatitis at Henry Ford Hospital
1958-1967
K. S. Murthy, M.D. and B. M . Schuman, M.D.*
An analysis was done to determine the risk of hepatitis related to transfusions
of whole blood or blood fractions. Of 180 cases indexed as serum hepatitis at
Henry Ford Hospital, from 1958 lo 1967, 148 had been transfused at this hospital. The overall incidence of hepatitis was 1.13 cases per 1,000 units transfused
with a mortality rale of 7.4%.

Clinicians are cognizant of the fact
that some of their patients wUl develop
serum hepatitis after transfusion of
whole blood or blood fractions. What
the actual risk may be in their particular hospital is not known unless it
has been calculated—because it is not
possible to apply data from other
studies in which a rate of from 1 to
15 cases per 1,000 units of blood has
been determined. We were interested in
knowing what the incidence of serum
hepatitis is at Henry Ford Hospital and
in determining the mortality rate for
this disease here. From such a study,
we anticipated answers to other important questions: Where does our
blood come from and does the source
of blood influence the incidence of
hepatitis? What is the risk of single
unit transfusion? What hospital departments carry the greatest risk for the
patient and why? Does the underlying
disease influence the development of
hepatitis or its course? To what extent
does the age, sex, or condition of the
patient influence the mortality from
hepatitis?

We hope that similar studies will be
undertaken in other large hospitals so
that an incidence survey will be obtained. By a comparison of data, factors that appear to lead to increased
incidence in any one hospital may be
altered.
Data Analysis
One hundred eighty cases of serum
hepatitis were indexed at Henry Ford
Hospital from 1958 to 1967. Of the
180 cases, 162 cases were related to
transfusions, of which 148 had been
transfused at this hospital. Eighteen
cases were related to contaminated
needles, 11 of which occurred in addicts, and this material was excluded
from analysis.
Table I summarizes the yearly incidence as related to transfusions. One
hundred and forty-eight cases were
observed during a period in which
129,731 units of blood and blood fractions were transfused giving an overall
incidence of 1.13 cases per 1000 units
transfused. No information is available
as to the number of patients receiving
these transfusions; hence, the attack
rate could not be ascertained. Fresh
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Year
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967

Table

Total
Number Number transIndexed fused at HFH

Units of blood &
blood fractions
transfused at HFH

Incidence |
1000 units
transfused

15
7
10
15
7
17
39
20
22
28

9
4
8
9
6
16
36
18
20
22

9032
9693
11208
12139
13082
14138
16444
15693
14839
13463

1.00
0.41
0.71
0.74
0.46
L13
2.19
1.15
1.35
1.56

180

148

129, 731

1.13

Incidence of Serum Hepatitis at HFH per 1,000 units transfused 1958-1967.

frozen plasma, salt poor albumin,
platelet concentrates, antihemophilic
globulin, fibrinogen and cryoprecipitates are not included in this data, but
the patients to whom these materials
were administered represent a relatively small group. Two patients with
hemophilia who received at various
times whole blood, packed red cells,
plasma, fresh frozen plasma and cryoprecipitates are included in the series.
Table I I summarizes the mode of infection. Seventy-eight percent of the
patients transfused received whole
blood.

changes in all specimens were consistent with hepatitis. The sex distribution was 82 male and 80 female
patients. The age range was from 17
to 89 years. The incidence by age
groups and its relation to mortality is
given in Table I I I . There was only one
death below the age of 54 years.
Twelve deaths occurred in the total
group giving a mortality rate of 7.4%,
but in eight patients the hepatitis was
considered mild or only moderately
severe and not the immediate cause
of death.
The number of transfusions given to
a patient was an important determinant
of hepatitis risk. This data is summarized in Table IV. Fifty-five percent of the patients received between
one and five transfusions. Eight cases
of hepatitis resulted from a single unit
transfusion. Of these, four were trans-

The diagnosis of hepatitis as recorded in the chart was accepted if it
was made on the basis of compatible
historical and laboratory criteria; all
cases were icteric. The incubation periods range from 20 to 220 days. Liver
biopsy was done in 23 cases, and
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Year

1958
1959
1960
1961
1962
1963
1964
1965
1966
1967

Table 11.

Transfusions
Whole blood RBC Plasma Mixed

Needle
Addict Other

9
7
8
8
7

3

1
2

13
28
15
15
17

2
4
1

2
4
2
5
4

2
2
2
5

127

10

23"

IT

Mode of Infection
16.6% (27 cases), and one case of
rubella prophylaxis and one of hemophilia.
Discussion
The reported incidence of viral hepatitis due to blood transfusion has
varied depending on the type of study
and the diagnostic criteria used. I n a
retrospective study,i employing the
criteria of icteric hepatitis or anicteric
hepatitis confirmed by biopsy or
autopsy, a hepatitis attack rate of 3%
was determined for patients who re^
ceived blood transfusions. Laureta et
al,- in another retrospective study,
reported an incidence of 2.3 cases of
icteric hepatitis per 1,000 units transfused and an attack rate of 0.9%. The
Boston Inter-Hospital Liver Group,^
however, reported a relatively low incidence of 0.6 cases of icteric hepatitis

fused during surgical operation, one
received a blood transfusion five days
before neck surgery, one was transfused for anemia, one was transfused
elsewhere (presumably for anemia),
and one patient received a single unit
plasma transfusion for rubella prophylaxis during pregnancy.
The indications for transfusion are
summarized in Table V. Blood replacement for surgery was an indication in
65.5%, the transfusion usually being
given during surgery or in the immediate post-operative period. Seventeen
cases were related to open heart surgery and the use of the heart-lung
machine. During this 10-year period of
study, there were 1,922 cases of pump
surgery, giving a hepatitis attack rate
of 0.88%. Other indications were hemorrhage 16.6% (27 cases), anemia
59
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Age
11-20
21-30
31-40
41-50
51-60
61-70
71-80
81-90

Number

Death

4
17
13
30'
38
4^
13
3

1
6
3
1

162

12~

1

Table III. Deaths as related to age
distribution of serum hepatitis patients
who received transfusions.
per 1,000 units transfused. Hampers
et al,* in a prospective study found
that 18% of transfused patients had
anicteric hepatitis. The ratio of anicteric to icteric cases was estimated to
be 100:1. In a prospective study based
on elevated transaminase levels,'' an astounding incidence of 64.5% was
found for transfused patients who developed "hepatitis" with or without
clinical manifestations.
In our study, the incidence was 1.13
cases of icteric hepatitis per 1,000 units

Number of

Number of

units transfused

patients

1
2-5
6-10
Above 10
Unknown

8
81
28
31
14
162

Table IV. Risk of hepatitis related
to number of units transfused.

60

transfused. The attack rate could not
be ascertained as we had no information on the number of patients. However, using the number of patients who
underwent pump surgery as a cross
section, the attack rate was 0.88%.
This figure is relatively low and probably reflects incomplete follow-up,
deaths occurring in the period immediately after transfusion, and nonrecognition of mild cases. Diagnostic
criteria also vary and influence the
data. Mild elevations of SGOT or
bilirubin may be attributed to other
factors, such as drug reactions, hemolysis or underlying primary conditions.
These problems of analysis, inherent
in any study, indicate the difficulty in
obtaining valid data.
The blood and blood fractions transfused were obtained from three
sources: (1) the Henry Ford Hospital
donor station where blood is obtained
from patients' relatives and from carefully-screened paid donors, (2) American Red Cross supervised blood banks,
and (3) commercial blood banks,
which provided approximately 30%
of the blood. A higher incidence of
serum hepatitis with the use of commercial blood has been noted' '* but,
from the data available, no correlation
could be established in our study between the use of commercial blood and
the incidence of serum hepatitis.
From January 1956 to 1967, the
pooled plasma at Henry Ford Hospital
was treated with 0.35% propiolactone
plus ultraviolet irradiation. During the
period of 1956-1961, only one case
of clinical hepatitis of questionable
source occurred among 425 plasma
recipients who were followed for a
period of at least six months.*' Between
1962 and 1967, no cases of hepatitis
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Indication for transfusion

Number of Patients

Surgery
General Surgery
Obstetrics & Gynecology
Thoracic
Pump Surgery
Other
Vascular
Orthopedic
Urology
Neurosurgery
Hemorrhage

28
23
17
6
9
9
12
2
27

Medical & Surgical Depts.
Anemia

27

Medical Services primarily
Other

?
162

Table V.

Indications for Transfusion
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occurred solely from treated pooled
plasma transfusions.^ FDA approval
for this method of virus sterilization
awaits confirmation of "efficacy" and
"lack of toxicity" by investigators
other than those at Henry Ford Hospital. [In Germany, however, where
over 100,000 units of Betaprone and
ultraviolet irradiated pooled human
serum have been distributed for clinical use since 1966, there have been
no reports of clinical hepatitis among
the recipients. The units came from
300 serum pools, of 10 gallons each,
given the combined treatment. On the
other hand, the same distributor (Biotest Serum Institute) had to withdraw
their nontreated human serum from
the market in 1965-66 because of the
incidence of hepatitis, even though this
was pooled in small volumes of only
six donors per pool.]^

of all the histories, there appeared to
be no abuse of transfusion requirements except in the three cases of
single unit hepatitis previously mentioned.
Thus, the epidemiological data offers no significant means of reducing
the incidence of serum hepatitis. Consideration might be given to the use of
gamma globulin to prevent or modify
the course of the disease.'^ However,
the available supply of gamma globulin
would be inadequate even if restricted
to selective high risk groups such as
the elderly and those patients receiving multiple transfusions.
It is obvious that the incidence of
serum hepatitis due to transfusion of
whole blood or any of its derivatives
will not be lowered until a routine
blood bank procedure is devised for
identifying the virus carrier state in a
blood donor. The discovery of the
Australia antigen, which appears to be
identical with the SH antigen ( A U /
SH antigen),"' '! and the development
of an immunodiffusion technique'^ for
detection of the antigen hold promise
for a practical screening test.
The mortality of the disease at our
hospital was surprisingly low. Allen
and Sayman' reported a mortality of
20% for patients over the age of 40
in contrast to the Boston Hospital
group'* which had an 11% fatality for
patients over 40 years of age. In our
study the mortality rate was 6.7% for
this age group. However, it should be
noted that only four deaths could be
directly attributable to serum hepatitis.
One death occurred in a 29-year-old
woman who had received multiple
transfusions for paroxysmal nocturnal
hemoglobinuria. She died in hepatic
coma shortly after the onset of her

Eight cases of serum hepatitis resulted from single unit transfusions.
Single unit transfusions administered
during surgery or because of hemorrhage are, perhaps, justifiable on the
grounds that one cannot predict improvement in the acute situation. But,
single unit transfusion prior to elective
surgery or for anemia is unwarranted.
Three cases in our series could have
been avoided by this clinical judgement.
The analysis of the data regarding
indications for transfusion according to
specialty service revealed no propensity
for patients with certain diseases to
become infected (Table V ) . The distribution of cases fit the pattern of
blood requirements for the type of
surgery performed. Transfusions given
for anemia were primarily for patients
with myeloproliferative disorders or
inoperable malignancy. From a review
62
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illness. The three other patients, who
died as a consequence of hepatitis, also
had received no corticosteroid therapy.
In the group of 19 patients treated with
steroids, there was only one death. This
death was due to myelosclerosis for
which the patient had been taking
prednisone prior to the onset of the
hepatitis. Surviving their hepatic infection in this corticosteroid treated group
were three patients under age 40 and
15 patients over 40, of whom three
had been treated for a long time with
corticosteroids for chronic disease.
This observation suggests that the
prompt institution of corticosteroid
therapy will reduce the case fatality of
this disease for patients over 40 years

of age who do not show progressive
recovery from hepatitis.
Summary
One hundred sixty-two cases of
serum hepatitis were observed at Henry
Ford Hospital from 1958 to 1967;
129,731 units of blood and blood fractions were transfused, an overall incidence of 1.13 bases per 1,000 units
transfused. There were 12 deaths during the course of hepatitis, an overall
mortality rate of 7.4%. However, only
four of the deaths were clearly related
to hepatic failure. Twelve patients over
age 40, treated with corticosteroids
because of either severity or chronicity
of the hepatitis, survived.
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